Back
Vericel Vs. Halozyme Therapeutics Industry Stock Comparison
Sell
29
VCEL
Vericel
Last Price:
46.36
Seasonality Move:
3.14%
Buy
60
HALO
Halozyme Therapeutics
Last Price:
62.32
Seasonality Move:
10.79%
Sell
29
Vericel (VCEL)
is a Sell
Is Vericel a Buy, Sell or Hold?
- The current Vericel [VCEL] share price is $46.35. The Score for VCEL is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
- VCEL is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
60
Halozyme Therapeutics (HALO)
is a Buy
Is Halozyme Therapeutics a Buy, Sell or Hold?
- The current Halozyme Therapeutics [HALO] share price is $62.31. The Score for HALO is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- HALO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
VCEL Stock Price Chart
HALO Stock Price Chart
What is Halozyme Therapeutics's stock price today?
-
The Halozyme Therapeutics share price today is $62.31
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HALO is experiencing slight selling pressure.
VCEL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.94 | Sell |
| Relative Strength Index (14 RSI): | 48.39 | Sell |
| Chaikin Money Flow: | 72527 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (44.49 - 50.09) | Sell |
| Bollinger Bands (100): | (44.74 - 50.08) | Sell |
HALO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.05 | Buy |
| Relative Strength Index (14 RSI): | 59.06 | Buy |
| Chaikin Money Flow: | -96167 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (59.62 - 63.1) | Buy |
| Bollinger Bands (100): | (45.2 - 59.3) | Buy |
VCEL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 44.59 | Buy |
| 20-day SMA: | 47.51 | Sell |
| 50-day SMA: | 48.24 | Sell |
| 200-day SMA: | 45.17 | Buy |
| 8-day EMA: | 45.43 | Buy |
| 20-day EMA: | 46.46 | Sell |
| 50-day EMA: | 47.23 | Sell |
| 200-day EMA: | 44.76 | Buy |
HALO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 60.99 | Buy |
| 20-day SMA: | 61.77 | Buy |
| 50-day SMA: | 57.93 | Buy |
| 200-day SMA: | 45.18 | Buy |
| 8-day EMA: | 61.61 | Buy |
| 20-day EMA: | 60.88 | Buy |
| 50-day EMA: | 57.95 | Buy |
| 200-day EMA: | 48.51 | Buy |
Vericel Earnings Growth & VCEL Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.10 per share, an increase this year of $0.29 per share, and an increase next year of $0.42 per share.
Halozyme Therapeutics Earnings Growth & HALO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.30 per share, an increase next quarter of $0.25 per share, an increase this year of $1.19 per share, and an increase next year of $0.84 per share.
Vericel Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Halozyme Therapeutics Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||